Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
InSightec Ltd Company Overview 6
InSightec Ltd Company Snapshot 6
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
InSightec Ltd – Pipeline Analysis Overview 8
InSightec Ltd – Key Facts 8
InSightec Ltd – Major Products and Services 9
InSightec Ltd Pipeline Products by Development Stage 10
InSightec Ltd Ongoing Clinical Trials by Trial Status 12
InSightec Ltd Pipeline Products Overview 14
ExAblate – Brain Cancer 14
ExAblate – Brain Cancer Product Overview 14
ExAblate – Brain Cancer Clinical Trial 15
ExAblate – Breast Cancer 16
ExAblate – Breast Cancer Product Overview 16
ExAblate – Breast Cancer Clinical Trial 17
ExAblate – Liver Cancer 18
ExAblate – Liver Cancer Product Overview 18
ExAblate 2100 Prostate System 19
ExAblate 2100 Prostate System Product Overview 19
ExAblate 2100 Prostate System Clinical Trial 20
ExAblate Neuro 21
ExAblate Neuro Product Overview 21
ExAblate Neuro Clinical Trial 22
Exablate Neuro – Alzheimer’s Disease 24
Exablate Neuro – Alzheimer’s Disease Product Overview 24
Exablate Neuro – Alzheimer’s Disease Clinical Trial 25
InSightec Ltd – Key Competitors 26
InSightec Ltd – Key Employees 27
InSightec Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
InSightec Ltd, Recent Developments 29
Jul 03, 2018: INSIGHTEC”s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare in Six Additional States 29
Jun 20, 2018: Insightec””s MRgFUS Earns Positive Nice Guidance For Treatment Of Essential Tremor 29
Jun 04, 2018: INSIGHTEC”s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare 30
May 14, 2018: INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson”s Disease 30
May 02, 2018: Focused Ultrasound Extends Its Focus: INSIGHTEC Initiates Parkinson”s Disease Study With First Patient Treated With Incisionless Brain Surgery 30
Feb 20, 2018: Israel Ministry of Health Includes INSIGHTEC’s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services 31
Nov 29, 2017: The Taiwanese Food and Drug Administration Approved Exablate Neuro for the Treatment of Essential Tremor 31
Oct 27, 2017: Insightec’s Exablate Neuro Named Best Medical Technology At Esteemed Prix Galien Awards 2017 32
Oct 25, 2017: INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson’s Disease 32
Aug 23, 2017: The First MR-Guided Focused Ultrasound Treatment for Essential Tremor Was Performed in Taiwan 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
InSightec Ltd Pipeline Products by Equipment Type 7
InSightec Ltd Pipeline Products by Indication 7
InSightec Ltd Ongoing Clinical Trials by Trial Status 7
InSightec Ltd, Key Facts 8
InSightec Ltd, Major Products and Services 9
InSightec Ltd Number of Pipeline Products by Development Stage 10
InSightec Ltd Pipeline Products Summary by Development Stage 11
InSightec Ltd Ongoing Clinical Trials by Trial Status 12
InSightec Ltd Ongoing Clinical Trials Summary 13
ExAblate - Brain Cancer - Product Status 14
ExAblate - Brain Cancer - Product Description 14
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Blood-brain Barrier Disruption Using Transcranial MRI-guided Focused Ultrasound with Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours with Doxorubicin 15
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 15
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 15
ExAblate - Breast Cancer - Product Status 16
ExAblate - Breast Cancer - Product Description 16
ExAblate - Breast Cancer - A Clinical Study to Evaluate the Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas 17
ExAblate - Liver Cancer - Product Status 18
ExAblate - Liver Cancer - Product Description 18
ExAblate 2100 Prostate System - Product Status 19
ExAblate 2100 Prostate System - Product Description 19
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions 20
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Low-intermediate Risk Prostate Cancer: Feasibility Study 20
ExAblate Neuro - Product Status 21
ExAblate Neuro - Product Description 21
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy 22
ExAblate Neuro - A Pivotal Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System 22
ExAblate Neuro - A Study to Evaluate the Effectiveness and Safety of Exablate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 22
ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Blood-brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy 22
ExAblate Neuro - Mapping Functional Networks of Brain Activity Using EEG in Patients with Essential Tremor or Parkinson Disease Before and after MR-guided Focused Ultrasound Thalamotomy for Tremor 23
Exablate Neuro - Alzheimer’s Disease - Product Status 24
Exablate Neuro - Alzheimer’s Disease - Product Description 24
Exablate Neuro - Alzheimer’s Disease - A Phase IIa Study to Evaluate the Safety and Efficacy of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-guided Focused Ultrasound in Patients with Alzheimer's Disease 25
Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease 25
InSightec Ltd, Key Employees 27
InSightec Ltd, Other Locations 28
Glossary 36
List of Figures
InSightec Ltd Pipeline Products by Equipment Type 7
InSightec Ltd Pipeline Products by Development Stage 10
InSightec Ltd Ongoing Clinical Trials by Trial Status 12
【免責事項】
http://www.globalresearch.jp/disclaimer